Event

The primary objective of this session is to increase HCP understanding of Type 2 inflammation and how it contributes to airway pathology in asthma. Evidence supporting roles for Type 2 cytokines in epithelial and airway smooth muscle pathology including remodeling, fibrosis, mucus production and airway hyperresponsiveness will be discussed. How these pathological features contribute to airway narrowing, progressive (and possibly irreversible) lung function decline and asthma symptoms will be reviewed in the context of poor asthma control.